Literature DB >> 25400466

Can composite performance measures predict survival of patients with colorectal cancer?

Kuo-Piao Chung1, Li-Ju Chen1, Yao-Jen Chang1, Yun-Jau Chang1.   

Abstract

AIM: To assess the relationship between long-term colorectal patient survival and methods of calculating composite performance scores.
METHODS: The Taiwan Cancer Database was used to identify patients who underwent bowel resection for colorectal adenocarcinoma between 2003 and 2004. Patients were assigned to one of three cohorts based on tumor staging: cohort 1, colon cancer stage < III; cohort 2, colon cancer stage III; cohort 3, rectal cancer. A composite performance score (CPS) was calculated for each patient using five different aggregating methods, including all-or-none, 70% standard, equal weight, analytic hierarchy process (AHP), and principal component analysis (PCA) algorithms. The relationships between CPS and five-year overall, disease-free, and disease-specific survivals were evaluated by a Cox proportional hazards model. A goodness-of-fit analysis for all five methods was performed using Akaike's information criterion.
RESULTS: A total of 3272 colorectal cancer patients (cohort 1, 1164; cohort 2, 790; cohort 3, 1318 patients) with a mean age of 65 years were enrolled in the study. Bivariate correlation analysis showed that CPS values from the equal weight method were highly correlated with those from the AHP method in all cohorts (all P < 0.05). Multivariate Cox hazards analysis showed that CPS values derived from equal weight and AHP methods were significantly associated with five-year survivals of patients in cohorts 1 and 2 (all P < 0.05). In these cohorts, higher CPS values suggested a higher probability of five-year survival. However, CPS values derived from the all-or-none method did not show any significant process-outcome relationship in any cohort. Goodness-of-fit analyses showed that CPS values derived from the PCA method were the best fit to the Cox proportional hazards model, whereas the values from the all-or-none model showed the poorest fit.
CONCLUSION: CPS values may highlight process-outcome relationships for patients with colorectal cancer in addition to evaluating quality of care performance.

Entities:  

Keywords:  Analytic hierarchy process; Colon cancer; Composite performance score; Patient survival; Performance measure; Principal component analysis; Rectal cancer

Mesh:

Year:  2014        PMID: 25400466      PMCID: PMC4229547          DOI: 10.3748/wjg.v20.i42.15805

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Evaluation of lymph nodes in patients with colon cancer undergoing colon resection: a population-based study.

Authors:  Yun-Jau Chang; Yao-Jen Chang; Li-Ju Chen; Kuo-Piao Chung; Mei-Shu Lai
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Estimating a composite measure of hospital quality from the Hospital Compare database: differences when using a Bayesian hierarchical latent variable model versus denominator-based weights.

Authors:  Michael Shwartz; Justin Ren; Erol A Peköz; Xin Wang; Alan B Cohen; Joseph D Restuccia
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

3.  Empirically derived composite measures of surgical performance.

Authors:  Douglas O Staiger; Justin B Dimick; Onur Baser; Zhaohui Fan; John D Birkmeyer
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

4.  Adherence to quality indicators and survival in patients with breast cancer.

Authors:  Skye H Cheng; C Jason Wang; Jin-Long Lin; Cheng-Fang Horng; Mei-Chun Lu; Steven M Asch; Lee H Hilborne; Mei-Ching Liu; Chii-Ming Chen; Andrew T Huang
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

5.  Prognostic and survival analysis of 837 Chinese colorectal cancer patients.

Authors:  Ying Yuan; Mo-Dan Li; Han-Guang Hu; Cai-Xia Dong; Jia-Qi Chen; Xiao-Fen Li; Jing-Jing Li; Hong Shen
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

6.  Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study.

Authors:  Stephen M Campbell; Martin O Roland; Elizabeth Middleton; David Reeves
Journal:  BMJ       Date:  2005-10-28

7.  Constructing a composite quality score for the care of acute myocardial infarction patients at discharge: impact on hospital ranking.

Authors:  Mélanie Couralet; Sophie Guérin; Marc Le Vaillant; Philippe Loirat; Etienne Minvielle
Journal:  Med Care       Date:  2011-06       Impact factor: 2.983

8.  Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems.

Authors:  Tomokazu Kawaoka; Hiroshi Aikata; Shintaro Takaki; Yoshimasa Hashimoto; Yoshio Katamura; Akira Hiramatsu; Koji Waki; Shoichi Takahashi; Koji Kamada; Mikiya Kitamoto; Toshio Nakanishi; Masaki Ishikawa; Masashi Hieda; Hideaki Kakizawa; Junko Tanaka; Kazuaki Chayama
Journal:  Hepatol Res       Date:  2010-09-28       Impact factor: 4.288

Review 9.  Treatment of locally advanced rectal cancer: controversies and questions.

Authors:  Atthaphorn Trakarnsanga; Suthinee Ithimakin; Martin R Weiser
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

10.  Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan.

Authors:  Kuo-Piao Chung; Yun-Jau Chang; Mei-Shu Lai; Raymond Nien-Chen Kuo; Skye H Cheng; Li-Tzong Chen; Reiping Tang; Tsang-Wu Liu; Ming-Jium Shieh
Journal:  BMC Health Serv Res       Date:  2010-01-27       Impact factor: 2.655

View more
  2 in total

1.  Adherence to quality indicators and hospital outcomes for patients with decompensated cirrhosis: An observational study.

Authors:  Krista R Wooller; Dominique Yelle; Stacy Fisher; Ian Carrigan; Erin Kelly
Journal:  Can Liver J       Date:  2020-11-17

2.  Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.

Authors:  Li-Ju Chen; Yun-Jau Chang; Yao-Jen Chang
Journal:  Oncologist       Date:  2020-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.